 SOUTH PLAINFIELD, N.J., July 28, 2021 PRNewswire -- PTC Therapeutics, Inc. NASDAQ: PTCT today announced that results from Part 2 of the FIREFISH pivotal study were published in the New England Journal of Medicine. 